Fundraising FoxBiophy
Philadelphia, US · 3 known investors
Find your way into Biophy
BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.
Founders & leadership
Board
Investors · 3
How we know: Metrodora Ventures's portfolio page · a partner's Signal profile · funding news · technical.ly · the VCSheet dataset · Not right? Tell us
How we know: pulse2.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$11.1M disclosed across 2 rounds · 2023–2025
- $4.5MraisedNov 2023 · 3 sources
Audere Capital, Metrodora Ventures, TRCM
Source ↗
▶$6.6MraisedMar 2025 · 56 investors · Other TechnologyRule 506(b)
- PHILIP BROWNEDirector
- CAITLIN JAYE-YANExecutive Officer
- DANIEL SCIUBBADirector
- DAVID LATSHAW IIExecutive Officer, Director
- Offering amount
- $6.6M
- Amount sold
- $6.6M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Biophy do?
- BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.
- Who are Biophy's investors?
- Biophy's investors include Metrodora Ventures, Audere Capital.
- How much funding has Biophy raised?
- Biophy has disclosed $11.1M raised across 2 rounds.
- Where is Biophy headquartered?
- Biophy is headquartered in Philadelphia, US.